Barclays PLC Bio Techne Corp Transaction History

Barclays PLC

$377 Billion
Q3 2024

A detailed history of Barclays PLC transactions in Bio Techne Corp stock. As of the latest transaction made, Barclays PLC holds 332,098 shares of TECH stock, worth $22.8 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

332,098

Previous 332,098 -0.0%

Holding current value

$22.8 Million

Previous $26.5 Million -0.0%

% of portfolio

0.01%

Previous 0.01%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	SELL	$70.96 - $82.35 $1.03 Million - $1.19 Million	-14,504 Reduced 4.18%	332,098 $26.5 Million
Q2 2024 Aug 14, 2024	BUY	$62.12 - $84.15 $53,485 - $72,453	861 Added 0.25%	346,602 $24.8 Million
Q1 2024 May 15, 2024	SELL	$65.98 - $77.09 $2.68 Million - $3.13 Million	-40,649 Reduced 10.52%	345,741 $24.3 Million
Q4 2023 Feb 15, 2024	BUY	$52.83 - $78.22 $4.16 Million - $6.17 Million	78,835 Added 25.63%	386,390 $29.8 Million
Q3 2023 Nov 07, 2023	BUY	$67.52 - $89.42 $566,492 - $750,233	8,390 Added 2.8%	307,555 $20.9 Million
Q2 2023 Aug 03, 2023	BUY	$73.76 - $85.98 $11.9 Million - $13.9 Million	161,922 Added 117.98%	299,165 $24.4 Million
Q1 2023 May 04, 2023	SELL	$71.62 - $86.62 $4.32 Million - $5.22 Million	-60,285 Reduced 30.52%	137,243 $10.2 Million
Q4 2022 Feb 13, 2023	BUY	$80.67 - $352.29 $12.7 Million - $55.6 Million	157,815 Added 397.39%	197,528 $16.4 Million
Q3 2022 Nov 03, 2022	BUY	$282.54 - $391.85 $3.15 Million - $4.37 Million	11,147 Added 39.02%	39,713 $11.3 Million
Q2 2022 Aug 12, 2022	SELL	$322.67 - $449.65 $6.6 Million - $9.19 Million	-20,449 Reduced 41.72%	28,566 $9.9 Million
Q1 2022 May 16, 2022	SELL	$353.85 - $487.79 $6.3 Million - $8.68 Million	-17,800 Reduced 26.64%	49,015 $21.2 Million
Q4 2021 Feb 14, 2022	BUY	$456.15 - $525.06 $1.94 Million - $2.23 Million	4,254 Added 6.8%	66,815 $34.6 Million
Q3 2021 Nov 09, 2021	BUY	$444.87 - $538.88 $5.8 Million - $7.03 Million	13,046 Added 26.35%	62,561 $30.3 Million
Q2 2021 Aug 13, 2021	BUY	$387.35 - $450.26 $17.4 Million - $20.2 Million	44,959 Added 986.81%	49,515 $22.3 Million
Q1 2021 May 13, 2021	BUY	$314.62 - $411.0 $704,434 - $920,229	2,239 Added 96.63%	4,556 $1.74 Million
Q4 2020 Feb 11, 2021	BUY	$246.9 - $321.87 $266,898 - $347,941	1,081 Added 87.46%	2,317 $736,000
Q3 2020 Nov 12, 2020	SELL	$232.22 - $282.96 $594,947 - $724,943	-2,562 Reduced 67.46%	1,236 $306,000
Q2 2020 Aug 12, 2020	SELL	$185.43 - $279.56 $3.59 Million - $5.41 Million	-19,365 Reduced 83.6%	3,798 $1 Million
Q1 2020 May 13, 2020	BUY	$161.17 - $221.51 $1.84 Million - $2.53 Million	11,405 Added 97.0%	23,163 $4.39 Million
Q4 2019 Feb 10, 2020	BUY	$189.68 - $222.09 $1.76 Million - $2.06 Million	9,284 Added 375.26%	11,758 $2.58 Million
Q3 2019 Nov 14, 2019	SELL	$183.56 - $216.72 $2.02 Million - $2.39 Million	-11,021 Reduced 81.67%	2,474 $485,000
Q2 2019 Aug 14, 2019	BUY	$188.72 - $215.43 $1.14 Million - $1.31 Million	6,067 Added 81.68%	13,495 $2.81 Million
Q1 2019 May 15, 2019	SELL	$136.09 - $200.44 $1.64 Million - $2.42 Million	-12,080 Reduced 61.92%	7,428 $1.48 Million
Q4 2018 Feb 14, 2019	BUY	$132.75 - $203.8 $649,280 - $996,785	4,891 Added 33.46%	19,508 $2.82 Million
Q3 2018 Nov 14, 2018	SELL	$147.44 - $204.11 $4.57 Million - $6.33 Million	-30,999 Reduced 67.96%	14,617 $2.98 Million
Q2 2018 Aug 14, 2018	BUY	$144.9 - $165.58 $3.39 Million - $3.87 Million	23,381 Added 105.15%	45,616 $6.75 Million
Q1 2018 May 15, 2018	SELL	$131.46 - $151.04 $940,596 - $1.08 Million	-7,155 Reduced 24.35%	22,235 $3.36 Million
Q4 2017 Feb 14, 2018	BUY	$121.17 - $134.75 $15,146 - $16,843	125 Added 0.43%	29,390 $3.81 Million
Q3 2017 Nov 14, 2017	BUY	$113.59 - $123.78 $3.32 Million - $3.62 Million	29,265	29,265 $3.54 Million

Others Institutions Holding TECH

# of Institutions

601

Shares Held

151M

Call Options Held

195K

Put Options Held

53.2K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.7B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account